09:33 AM EST - Oncolytics Biotech Inc. : Announced the acceptance of an abstract discussing its pancreatic adenocarcinoma trial at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place virtually from June 4 – 8, 2021. Details on the abstract and a corresponding poster presentation are shown below. The abstract will be published on the ASCO Annual Meeting website at 5:00 p.m. ET on May 19, 2021 . The corresponding poster will be made available on the meeting website at 9:00 a.m. ET on June 4, 2021. Oncolytics Biotech Inc.
shares T.ONC are trading up 3 cents at $3.78.
